Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Clinical trial NCT01082367 · COMPLETED

Trial details

NCT number: NCT01082367
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

Start date: 2010-04-01
Primary completion: 2015-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.